Company / R&D per Share
CONMED Corporation R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.79
FY2025
5-year range
$1.35 / $1.79
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
#52 of 109
Health Care
What the data says
At $1.79, CONMED Corporation's r&d per share ranks #52 of 109 in the Health Care sector. R&D per Share has increased for 4 consecutive years, from $1.35 in FY2021 to $1.79 in FY2025.
Based on SEC 10-K filings.
1.79 in FY2025 with a 5-year CAGR of +5.5%.
Improved from $1.67 to $1.79 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +4.6%
- 5-Year CAGR
- +5.5%
- 10-Year CAGR
- -
Sector benchmark
#52 of 109 in Health CareTop 48% of 109This company $1.79 Sector average $2.08
▼
-13.6% below sector average
Key checks
Key Insights
- CONMED Corporation's r&d per share has grown for 4 consecutive years.
- In FY2025, r&d per share increased 2.7% year-over-year.
- Ranks #52 out of 109 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.79 | +2.7% |
| FY2024 | $1.75 | +4.8% |
| FY2023 | $1.67 | +6.2% |
| FY2022 | $1.57 | +16.1% |
| FY2021 | $1.35 | -1.6% |
| FY2020 | $1.37 | -10.9% |
| FY2019 | $1.54 | +5.5% |
| FY2018 | $1.46 | +27.3% |
| FY2017 | $1.15 | -0.6% |
| FY2016 | $1.15 | +18.2% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026